Engel Publishing Partners Overview
- Latest Deal Type
- Financing Rounds
Engel Publishing Partners General Information
Publisher of business magazines.The company provides business news, including business strategy, financial news, generics, legal actions, and patent issues; marketing and advertising news, such as agency news, electronic marketing news, and product marketing news; and conference news. It also offers therapeutic news on cardiovascular, oncology, pain and inflammation, central nervous system, and infectious diseases; research and development news, including contract research business, drug approvals, drug discovery, drugs in development, and trial results. In addition, it provides reports for biotechnology, company analysis, drug delivery, drug development, healthcare sales and marketing, pipeline data, strategic issues, and therapeutic areas. Further, the company offers various interactive products, data tools, eNewsletter series, and special reports. It also hosts various industry conferences, summits, and award functions. It is a niche B2B media company serving the $634 billion global pharmaceutical market.
- 828 Newtown Yardley Road
- Newtown, PA 18940
- United States
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Engel Publishing Partners Valuation & Funding
Engel Publishing Partners Signals
Engel Publishing Partners Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|